Kelly Schick
Oficial de Recursos Humanos en C4 THERAPEUTICS, INC. .
Fortuna: 326 046 $ al 30/04/2024
Cargos activos de Kelly Schick
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
C4 THERAPEUTICS, INC. | Oficial de Recursos Humanos | 12/01/2021 | - |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Corporate Officer/Principal | - | - |
Historial de carrera de Kelly Schick
Antiguos cargos conocidos de Kelly Schick.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2011 | - |
AMAG PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | 01/09/2016 | - |
Formación de Kelly Schick.
Boston University | Undergraduate Degree |
The Curtis L. Carlson School of Management | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Corporate Officer/Principal | 2 |
Human Resources Officer | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
C4 THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services ScripNet LLC engages in the management of employee benefits. It offers account management, formulary development, pharmacy network, stewardship program review and transparent pricing model. The company was founded by Dennis M. Sponer in 1997 and is headquartered in Las Vegas, NV. | Technology Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Kelly Schick
- Experiencia